The enactment of statewide laws permitting the use of cannabis for therapeutic purposes is associated with an annual reduction in obesity-related medical costs, according to data published online ahead of print in the journal Health Economics. Researchers reported, “[T]he enforcement of MMLs (medical marijuana laws) is associated with a 2% to 6% decline in the probability of obesity. … Our estimates suggest that MMLs induce a $58 to $115 per-person annual reduction in obesity-related medical costs.”
Current consumers of cannabis are 50 times less likely to suffer from metabolic syndrome as compared to those who have never used the substance, according to findings published online ahead of print in The American Journal of Medicine. Metabolic syndrome is a group of risk factors, including high blood pressure, high blood sugar, unhealthy cholesterol levels, and abdominal fat, which are linked to increased risk of heart disease and/or diabetes, among other serious health consequences.